Wintrust Investments LLC Raises Holdings in VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)
Wintrust Investments LLC raised its holdings in shares of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH) by 10.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 10,820 shares of the company’s stock after purchasing an additional 1,050 shares during the period. Wintrust Investments LLC owned approximately 0.37% of VanEck Vectors Pharmaceutical ETF worth $635,000 at the end of the most recent quarter.
Separately, Bank of Montreal Can boosted its stake in VanEck Vectors Pharmaceutical ETF by 14.8% during the 1st quarter. Bank of Montreal Can now owns 3,110 shares of the company’s stock valued at $189,000 after purchasing an additional 400 shares during the last quarter.
PPH traded up $0.69 during trading on Wednesday, hitting $57.33. 50 shares of the company’s stock traded hands, compared to its average volume of 48,088. The company’s 50 day simple moving average is $57.44 and its two-hundred day simple moving average is $58.45. VanEck Vectors Pharmaceutical ETF has a 12-month low of $52.39 and a 12-month high of $64.90.
See Also: What are convertible shares?
Receive News & Ratings for VanEck Vectors Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Vectors Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.